Literature DB >> 33426085

Association between LXR-α and ABCA1 Gene Polymorphisms and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus in a Chinese Han Population.

Peng Liu1, Liang Ma2, Hailing Zhao3, Zhengri Shen1, Xuefeng Zhou3, Meihua Yan3, Tingting Zhao3, Haojun Zhang3, Xinping Qiu1, Ping Li3.   

Abstract

We designed a case-control study and selected LXRrs7120118 C>T and ABCA1 rs2230806 A>G polymorphisms to determine the correlation between these polymorphisms and diabetic kidney disease (DKD) susceptibility in a Chinese Han population. Three hundred DKD patients and 346 type 2 diabetes mellitus (DM) patients without kidney disease were recruited. Our results showed that rs7120118 was associated with DKD (genotype, P = .027; allele, P < .011). rs7120118 was associated with a higher risk of DKD under a dominant model adjustment by age and sex (P = .015) and an additive model (P = .040); rs2230806 was associated with a higher risk of DKD under an recessive model (P < .03); the combined effect of rs7120118 CC+rs2230806 GG genotype showed an association of DKD adjustment for age and sex (P = .009). In subgroup analysis of patients without hypercholesterolemia, the rs2230806 genotype frequencies were different between the two groups (P = .042). rs2230806 was associated with increased risk of DKD under a recessive model adjustment for age and sex (P = .013) and an additive model (P = .031). Our results suggest that LXRrs7120118 is significantly associated with a higher risk of DKD, and ABCA1 rs2230806 is significantly associated with a higher risk of DKD without hypercholesterolemia in Chinese Han individuals.
Copyright © 2020 Peng Liu et al.

Entities:  

Year:  2020        PMID: 33426085      PMCID: PMC7772016          DOI: 10.1155/2020/8721536

Source DB:  PubMed          Journal:  J Diabetes Res            Impact factor:   4.011


  2 in total

Review 1.  Insights into the antitumor mechanism of ginsenosides Rg3.

Authors:  Zongyu Liu; Tongjun Liu; Wei Li; Jiannan Li; Cuizhu Wang; Kai Zhang
Journal:  Mol Biol Rep       Date:  2021-03-04       Impact factor: 2.316

Review 2.  Administration of mesenchymal stem cells in diabetic kidney disease: mechanisms, signaling pathways, and preclinical evidence.

Authors:  Yuexin Zhu; Manyu Luo; Xue Bai; Yan Lou; Ping Nie; Shan Jiang; Jicui Li; Bing Li; Ping Luo
Journal:  Mol Cell Biochem       Date:  2022-04-25       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.